Endogenous Depressions with and Without Disturbances in the 5-hydroxytryptamine Metabolism: A Biochemical Classification?

Overview

Journal Psychopharmacologia

Specialty Pharmacology

Date 1971 Jan 1

PMID 5565735

Citations 19

Authors

J Korf

H M van Praag

Affiliations

Soon will be listed here.

Citing Articles

Circuits Regulating Pleasure and Happiness-Mechanisms of Depression.

Loonen A, Ivanova S Front Hum Neurosci. 2016; 10:571.

PMID: 27891086 PMC: 5102894. DOI: 10.3389/fnhum.2016.00571.

Csf 5 - hiaa in violent and non-violent suicide attempters.

Trivedi J, Pandey S, Dalal P, Dubey M, Sinha P Indian J Psychiatry. 2011; 39(1):41-8.

PMID: 21584043 PMC: 2967082.

Historical studies of premenstrual tension up to 30 years ago: implications for future research.

Janowsky D, Rausch J, Davis J Curr Psychiatry Rep. 2002; 4(6):411-8.

PMID: 12441020 DOI: 10.1007/s11920-002-0068-8.

Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study.

Pedersen O, Kragh-Sorensen P, Bjerre M, Overo K, Gram L Psychopharmacology (Berl). 1982; 77(3):199-204.

PMID: 6812140 DOI: 10.1007/BF00464566.

Plasma levels of zimelidine and norzimelidine in endogenous depression.

Hansen L, Thomsen I, Vestergard P, Larsen N, Hvidberg E Psychopharmacology (Berl). 1980; 69(2):157-60.

PMID: 6450427 DOI: 10.1007/BF00427642.

References

Ashcroft G, Crawford T, Eccleston D, SHARMAN D, MACDOUGALL E, Stanton J . 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet. 1966; 2(7472):1049-52. DOI: 10.1016/s0140-6736(66)92028-9. View

Coppen A, Shaw D, Herzberg B, Maggs R . Tryptophan in the treatment of depression. Lancet. 1967; 2(7527):1178-80. DOI: 10.1016/s0140-6736(67)91894-6. View

Carroll B, MOWBRAY R, Davies B . Sequential comparison of L-tryptophan with E.C.T. in severe depression. Lancet. 1970; 1(7654):967-9. DOI: 10.1016/s0140-6736(70)91096-2. View

Korf J, van Praag H . The intravenous probenecid test: a possible aid in evaluation of the serotonin hypothesis on the pathogenesis of depressions. Psychopharmacologia. 1970; 18(1):129-32. DOI: 10.1007/BF00402393. View

van Praag H, Korf J . A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biol Psychiatry. 1971; 3(2):105-12. View

Korf J, van Praag H, Sebens J . Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochem Pharmacol. 1971; 20(3):659-68. DOI: 10.1016/0006-2952(71)90152-3. View

Korf J . Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid. Clin Chim Acta. 1969; 26(2):301-6. DOI: 10.1016/0009-8981(69)90383-0. View

van Praag H . [Depression and metabolism of 5-hydroxytryptamine]. Ned Tijdschr Geneeskd. 1969; 113(50):2245-8. View

BOWERS Jr M . 5-hydroxyindoleacetic acid in the brain and cerebrospinal fluid of the rabbit following administration of drugs affecting 5-hydroxytryptamine. J Neurochem. 1970; 17(6):827-8. DOI: 10.1111/j.1471-4159.1970.tb03357.x. View

10.

van Praag H, Korf J, Puite J . 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature. 1970; 225(5239):1259-60. DOI: 10.1038/2251259b0. View

11.

Forn J, MALING H, Gessa G . Homovanillic and 5-hydroxyindoleacetic acids in cerebrospinal fluid after probenecid: measurement of brain monoamine oxidase inhibition in vivo. Proc Soc Exp Biol Med. 1970; 133(4):1310-3. DOI: 10.3181/00379727-133-34678. View

12.

BOWERS Jr M . CSF homovanillic acid: effects of probenecid and alpha-methyltyrosine. Life Sci I. 1970; 9(12):691-4. View

13.

Korf J, van Praag H . Retarded depression and the dopamine metabolism. Psychopharmacologia. 1971; 19(2):199-203. DOI: 10.1007/BF00402643. View

14.

van Praag H, ULEMAN A, SPITZ J . The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. Psychiatr Neurol Neurochir. 1965; 68(5):329-46. View

15.

Guldberg H, Ashcroft G, Crawford T . Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid. Life Sci. 1966; 5(17):1571-5. DOI: 10.1016/0024-3205(66)91026-5. View

16.

Neef N, Tozer T, Brodie B . Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J Pharmacol Exp Ther. 1967; 158(2):214-8. View